Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why.
Read more on NPR
Monday, 20 January 2020
loobobilly News: Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic
Labels:
Business
,
loobobillyNPR
Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why.
Read more on NPR
Do You Like This Article
Get Subscribe to Free Email Updates!!
Popular Posts
-
Judge to dismiss Sarah Palin lawsuit against 'New York Times' A federal judge will dismiss Sarah Palin's defamation lawsuit agai...
-
It's one of the most lavish days on the Australian horse racing calendar, but the 2016 Caulfield Cup race day in Melbourne showed ...
-
She'll soon make her debut as a judge on America's Next Top Model. And Ashley Graham gave a lesson in fierce and fabulous p...
-
Sometimes people forget that old guys can be geeks. This week: How Samsung helped Apple, will Verizon win a discount, and a new riff on a cl...
-
Internet shutdowns cost India $968 million (Rs 6,485 crore) in 2015-16, the largest loss among 19 countries surveyed and the result of 2...
-
Microsoft pushed out a big update to its operating system this summer, and you can confirm whether your PC has it through a few quick steps....
-
Forbes published its first list of the wealthiest cryptocurrency holders, even as recent price declines have shrunk the value of their fortu...
